Supplemental Reading for Chapter 1 Basic Principles of Clinical ...

5-14 Cardiovascular Pharmacotherapeutics
term b blockade on aortic root compliance in patients
with Marfan syndrome. Am Heart J 137:1057,
1999.
346. Rossi-Foulkes R, Roman MJ, Rosen SE, et al: Phenotypic
features and impact of beta blocker or calcium
antagonist therapy on aortic lumen size in the
Marfan Syndrome. Am J Cardiol 83:1364, 1999.
346a. Ong K-T, Perdu J, DeBacker J, et al: Effect of celiprolol
on prevention of cardiovascualr events in
vascular Ehlers-Danlos syndrome: a prospective
randomised, open, blinded-endpoints trial. Lancet
376: 1476, 2010.
347. Shimizu W, Antzelevitch C: Differential effects of
beta-adrenergic agonists and antagonists in LQT1,
LQT2 and LQT3 models of the long QT syndrome.
J Am Coll Cardiol 35:778, 2000.
348. Moss AJ, Zareba W, Hall WJ, et al: Effectiveness
and limitations of b blocker therapy in congenital
long QT syndrome. Circulation 101:616, 2000.
349. Dorostkar PC, Eldar M, Belhassen B, Scheinman
MM: Long-term follow-up of patients with long
QT syndrome treated with b blockers and continuous
pacing. Circulation 100:2431, 1999.
350. Hedblad B, Wikstrand J, Janson L, et al: Low-dose
metoprolol CR/XL and fluvastatin slow progression
of carotid intima-media thickness. Main results
from the b Blocker Cholesterol-Lowering
Asymptomatic Plaque Study (BCAPS). Circulation
103:1721, 2001.
351. Sipahi I, Tuzcu EM, Wolski KE, et al: b Blockers and
progression of coronary atherosclerosis: pooled
analysis of 4 intravascular ultrasonography trials.
Ann Intern Med 147: 10,2007.
352. Magsino CH Jr, Hamouda W, Bapna V, et al: Nadolol
inhibits reactive oxygen species generation by
leukocytes and linoleic acid oxidation. Am J Cardiol
86:443, 2000.
353. The Propranolol Aneurysm Trial Investigators:
propranolol for small abdominal aortic aneurysms:
results of a randomized trial. J Vasc Surg 35:72,
2002.
354. Mahanonda N, Bhuripanyo K, Kangkagate C, et
al: Randomized, double-blind, placebo-controlled
trial of oral atenolol in patients with unexplained
syncope and positive upright tilt table test results.
Am Heart J 130:1250, 1995.
355. Cox MM, Perlman BA, Mayor MR, et al: Acute and
long-term beta-adrenergic blockade for patients
with neurocardiogenic syncope. J Am Coll Cardiol
26:1293, 1995.
356. Iskos D, Dutton J, Scheinman MM, Lurie KG: Usefulness
of pindolol in neurocardiogenic syncope.
Am J Cardiol 82:1121, 1998.
357. Madrid AH, Ortego J, Rebollo JG, et al: Lack of
efficacy of atenolol for the prevention of neurally
mediated syncope in a highly symptomatic population:
a prospective, double-blind, randomized and
placebo-controlled study. J Am Coll Cardiol 37:554,
2001.
358. Harte B, Jaffer AK: Perioperative beta-blockers
in noncardiac surgery: evolution of the evidence.
Cleveland Clinic J Med 75: 513,2008.
359. Mangano DT, Layug EL, Wallace A, Tateo I: Effect
of atenolol on mortality and cardiovascular morbidity
after noncardiac surgery. Multicenter study
of perioprative ischemia research group. N Engl J
Med 335:1713, 1996.
360. Poldermans D, Boersma E, Bax JJ, et al for the
Dutch Echocardiographic Cardiac Risk Evaluation
Applying Stress Echocardiography Study Group:
the effect of bisoprolol on peri-operative mortality
and myocardial infarction in high-risk patients undergoing
vascular surgery. N Engl J Med 341:1789,
1999.
361. Shojania KG, Duncan BW, McDonald KM, et al:
Making health care safer: A critical analysis of
patient safety practices. Evid Rep Technol Assess
(Summ) 43: 1,2003.
362. National Quality Forum: Safe practices for better
healthcare – 2006 update. Washington, DC: National
Quality Forum, 2006.
363. POISE Study Group: Effects of extended-release
metoprolol succinate in patients undergoing noncardiac
surgery (POISE Trial): a randomized, controlled
trial. Lancet 371; 1839,2008.
364. Fleisher LA, Poldermans D: Perioperative b blockade:
where do we go from here? (commentary).
Lancet 371: 1813,2008.
364a. Chopra V, Eagle KA: Perioperative b-blockers for
cardiac risk reduction. Time for clarity (commentary).
JAMA 303: 551, 2010.
365. Fleisher LA, Beckman JA, Buller CE, et al: 2009
ACCF/AHA focused update on perioperative beta
blockade. A report of the American College of Cardiology
Foundation/American Heart Association
Task Force on Practice Guidelines. J Am Coll Cardiol
54: e13, 2009.
366. Poldermans D, Bax JJ, Boersma E, et al: Guidelines
for pre-operative cardiac risk assessment and
peri-operative cardiac management in non-cardiac
surgery: The Task Force for Preoperative Cardiac
Risk Assessment and Perioperative Cardiac Management
in Non-cardiac surgery of the European
Society of Cardiology (ESC) and endorsed by the
European Society of Anaesthesiology (ESA). Eur J
Anaesthesiol 27: 92, 2010.
367. Han JA, Frishman WH, Sun SW, et al: Cardiovascular
and respiratory considerations with pharma-